Allergic reaction in a cohort of haemophilia A patients using plasma‐derived factor VIII (FVIII) concentrate is rare and not necessarily triggered by FVIII

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2516|21|4|e281-e285

ISSN： 1351-8216

Source： HAEMOPHILIA, Vol.21, Iss.4, 2015-07, pp. : e281-e285

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetics of plasma‐derived vs. recombinant FVIII concentrates: a comparative study

By  

HAEMOPHILIA, Vol. 21, Iss. 2, 2015-03 ,pp. : 204-209

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rituximab and intermediate‐purity plasma‐derived factor VIII concentrate (Koate®) as adjuncts to therapeutic plasma exchange for thrombotic thrombocytopenic purpura in patients with an ADAMTS13 inhibitor

By  

JOURNAL OF CLINICAL APHERESIS, Vol. 30, Iss. 1, 2015-02 ,pp. : 50-54

John Wiley & Sons Inc

Access to resources Recommend Favorite

Switching to low dose of plasma‐derived factor VIII/vWF concentrates with Confact®‐F as salvage immune tolerance induction in haemophilia A patients with inhibitors: five case reports from Japan

By  

HAEMOPHILIA, Vol. 1351-8216, Iss. 5, 2015-09 ,pp. : e425-e427

John Wiley & Sons Inc

Access to resources Recommend Favorite

Switching to low dose of plasma‐derived factor VIII/vWF concentrates with Confact®‐F as salvage immune tolerance induction in haemophilia A patients with inhibitors: five case reports from Japan

By  

HAEMOPHILIA, Vol. 21, Iss. 5, 2015-09 ,pp. : e425-e427

John Wiley & Sons Inc

Access to resources Recommend Favorite

Parameters influencing FVIII pharmacokinetics in patients with severe and moderate haemophilia A

By  

HAEMOPHILIA, Vol. 21, Iss. 3, 2015-05 ,pp. : 343-350

John Wiley & Sons Inc

Access to resources Recommend Favorite